Pregnancy Predictors after Intrauterine Insemination in Cases of Unexplained Infertility: A Prospective Study

The Effect of Luteal Phase Support on Pregnancy Rates of the Stimulated Intrauterine Insemination Cycles in Couples with Unexplained Infertility

Background To assess the efficacy of luteal phase support (LPS) with vaginal progesterone (P) on pregnancy rates of the stimulated intrauterine insemination (IUI) cycles in couples with unexplained infertility (UEI). MaterialsAndMethods This was a single-center, prospective, randomized, blinded control trial undertaken at a tertiary care university fertility center between October 2007 and Dece...

The effect of sperm morphology on IUI outcome in cases with unexplained and male factor infertility

Background: Although intrauterine insemination (IUI) is one of the most common methods which is used for male factor and unexplained infertility, the relative influence of various semen parameters on the likelihood of a successful outcome is controversial. Several semen parameters have been evaluated as predictors of a successful outcome with intrauterine insemination. Objective: To evaluate th...

Effect of Pertubation on Pregnancy Rates before Intrauterine Insemination Treatment in Patients with Unexplained Infertility

P-189: Effect of Piroxicam Administration on Pregnancy Rate in Intrauterine Insemination (IUI) Cycles: A Randomized Clinical Trial

Background: To investigate the effect of administering piroxicam on improving the success rate of IUI cycles in those suffering from unexplained infertility. Materials and Methods: This was a randomized clinical trial being performed at Ghadir Mother and Child Hospital and Motahari clinics of Shiraz University of Medical Sciences. We included 260 women with unexplained infertility selected for ...

P-101: Advantages of Recombinant Follicle- Stimulating Hormone over Human Menopausal Gonadotropin for Ovarian Stimulation in Intrauterine Insemination: A Randomized Clinical Trial in Unexplained Infertility

Background To compare two different gonadotropin preparations, human menopausal gonadotropin (hMG) and recombinant follicle-stimulating hormone (rFSH), combined with clomiphene citrate (CC) in women with unexplained infertility undergoing intrauterine insemination (IUI). MaterialsAndMethods In this prospective clinical trial, couples prepared for IUI cycles were randomly allocated to two groups...